Refractory anemia with excess of blast cells: Prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients
- 1 December 1979
- Vol. 44 (6), 1976-1982
- https://doi.org/10.1002/1097-0142(197912)44:6<1976::aid-cncr2820440603>3.0.co;2-#
Abstract
The results of a prospective study of 58 patients with refractory anemia and partial blastic infiltration of the bone marrow lead to the following conclusions. The median survival (12 months from diagnosis) is shorter and the rate of acute leukemia as cause of death (60%) higher than in other retrospective series. This group of patients, however, appears to be a "continuum" of preleukemic states with more or less rapid evolution, so that the exclusion of the most severe cases appears unjustified. Based on the degree of bone marrow blastosis, and also on the degree of blood cytopenias, the anomalies of 59 Fe incorporation kinetics and the bone marrow stem-cell cultures, it is possible to derive a plausible prognosis for individual patients, which could aid the choice of therapy. Androgen therapy does not accelerate leukemic evolution, but does not improve the bone marrow insufficiency. Cytosine-arabinoside at low dosage exhibited no toxicity, but did not delay the appearance of overt leukemia.Keywords
This publication has 10 references indexed in Scilit:
- PreleukemiaPublished by Springer Nature ,1979
- Refractory Anaemia with Excess of Myeloblasts in the Bone Marrow: a Clinical Trial of Androgens in 90 PatientsBritish Journal of Haematology, 1977
- PreleukemiaActa Medica Scandinavica, 1975
- CELLULARITY AND CELL PROLIFERATION RATES IN HUMAN BONE MARROWActa Medica Scandinavica, 1974
- Human PreleukemiaNew England Journal of Medicine, 1973
- Defective in Vitro Colony Formation by Human Bone Marrow Preceding Overt LeukaemiaBritish Journal of Haematology, 1972
- Granulopoiesis in Acute Myeloid Leukemia and PreleukemiaNew England Journal of Medicine, 1971
- Myelomonocytic leukemia: Disorderly proliferation of all marrow cellsCancer, 1971
- Chronic erythromonocytic leukemiaAmerican Journal Of Medicine, 1969
- Smoldering Acute LeukemiaNew England Journal of Medicine, 1963